FDA publishes new GMP Guide for Cosmetic Products
![Drug Master File Procedures in the EU, the US and Japan - Live Online Training](files/eca/userImages/training.img/Z-ECA-Drug-Master-File-Procedures-LOT.jpg)
Recommendation
17/18 September 2024
With updates on the CEP 2.0!
On June 25, 2013 the US FDA published a new Good Manufacturing Practice Guide for Cosmetic Products. This new draft Guideline includes recommendations on documentation, recordkeeping, buildings and facilities, equipment, raw materials, production, internal audits, laboratory controls, handling of complaints and reports of adverse events as well as on conducting recalls.
The new guidance document revises the existing “Cosmetic Good Manufacturing (GMP) Guidelines/Inspection Checklist” by updating it to set forth current practice, and clarify certain topic areas based on recent experience. In addition the FDA intends to harmonize their own requirments with those published by the International Organization for Standardization (ISO) standard for cosmetic GMPs (ISO 22716:2007). However, FDA has only incorporated elements of ISO 22716, as appropriate, and consistent with FDA regulations. Some ISO requirements have not been transfered to the new FDA Guide. But also some additional requirements not included in the ISO 22716 have been incorporated in the guide. The Guide also refers to a Guidance for Industry on Cosmetics Processors and Transporters of Cosmetics Security Preventive Measures which was already revised in October 2007. Different to most other FDA Guidance documents this Guidance for Industry is also available in Dutch, German, French, Arabic, Korean, Thai as well as in Chinese language.
Reference: June 2013 revision of the Guidance for Industry: Cosmetic Good Manufacturing Practices
Related GMP News
24.07.2024FDA Warning Letter to a Manufacturer of an Athlete Muscle Maintenance Creme
24.07.2024FDA describes detailed CAPA Procedure in Warning Letter
17.07.2024Congressional Scrutiny on FDA's Foreign Inspection Program puts Pressure on Agency
19.06.2024More FDA Inspections again - also in the EU?
12.06.2024GMP Problems with critical Medicinal Products - what now?
15.05.2024Lack of Quality Oversight: EU Non-Compliance Report issued to Omeprazole Manufacturer